Market Closed -
Oslo Bors
15:45:00 10/05/2024 BST
|
5-day change
|
1st Jan Change
|
2.33
NOK
|
+4.48%
|
|
0.00%
|
-67.64%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
555.2
|
837.6
|
416.2
|
206.6
|
51.58
|
18.9
|
-
|
-
|
Enterprise Value (EV)
1 |
538.5
|
776.4
|
293
|
201.1
|
51.58
|
-150.1
|
-26.31
|
18.9
|
P/E ratio
|
-3.6
x
|
-6.91
x
|
-2.01
x
|
-2.03
x
|
-0.44
x
|
0.4
x
|
-1.09
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
247
x
|
1,342
x
|
-
|
20.7
x
|
419
x
|
0.09
x
|
0.2
x
|
0.07
x
|
EV / Revenue
|
239
x
|
1,244
x
|
-
|
20.1
x
|
419
x
|
-0.75
x
|
-0.28
x
|
0.07
x
|
EV / EBITDA
|
-3.68
x
|
-7.75
x
|
-3.11
x
|
-1.99
x
|
-0.52
x
|
346
x
|
0.75
x
|
0.19
x
|
EV / FCF
|
-3.56
x
|
-7
x
|
-3.43
x
|
-
|
-
|
3.34
x
|
-
|
-
|
FCF Yield
|
-28.1%
|
-14.3%
|
-29.2%
|
-
|
-
|
30%
|
-
|
-
|
Price to Book
|
-
|
2.25
x
|
1
x
|
0.62
x
|
-
|
4.09
x
|
58.3
x
|
-
|
Nbr of stocks (in thousands)
|
2,113
|
2,884
|
6,278
|
6,282
|
7,164
|
8,110
|
-
|
-
|
Reference price
2 |
262.8
|
290.4
|
66.30
|
32.88
|
7.200
|
2.330
|
2.330
|
2.330
|
Announcement Date
|
11/03/20
|
18/02/21
|
17/02/22
|
16/02/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2.251
|
0.624
|
-
|
10
|
0.123
|
200
|
93
|
272
|
EBITDA
1 |
-146.2
|
-100.2
|
-94.29
|
-100.9
|
-98.73
|
-0.4333
|
-35
|
98
|
EBIT
1 |
-150.3
|
-103.9
|
-95.6
|
-102.3
|
-100.5
|
8.735
|
-66.16
|
-
|
Operating Margin
|
-6,675.83%
|
-16,650.8%
|
-
|
-1,022.44%
|
-81,709.76%
|
4.37%
|
-71.13%
|
-
|
Earnings before Tax (EBT)
1 |
-147.8
|
-108.4
|
-98.02
|
-102.6
|
-110.7
|
7.765
|
-67.18
|
-
|
Net income
1 |
-147.5
|
-108.1
|
-97.97
|
-102.5
|
-110.7
|
-1.823
|
-67.18
|
198
|
Net margin
|
-6,553.93%
|
-17,327.88%
|
-
|
-1,025.16%
|
-90,029.27%
|
-0.91%
|
-72.24%
|
72.79%
|
EPS
2 |
-72.90
|
-42.00
|
-33.00
|
-16.20
|
-16.33
|
5.824
|
-2.129
|
-
|
Free Cash Flow
1 |
-151.1
|
-110.9
|
-85.4
|
-
|
-
|
-45
|
-
|
-
|
FCF margin
|
-6,711.59%
|
-17,766.51%
|
-
|
-
|
-
|
-22.5%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/03/20
|
18/02/21
|
17/02/22
|
16/02/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
---|
Net sales
1 |
0.59
|
-
|
-
|
-
|
-
|
-
|
-
|
10
|
EBITDA
1 |
-56.96
|
-45.51
|
-22.2
|
-25.18
|
-28.73
|
-30.38
|
-19.94
|
-21.81
|
EBIT
1 |
-58.99
|
-
|
-22.54
|
-25.52
|
-29.07
|
-30.71
|
-20.28
|
-22.2
|
Operating Margin
|
-9,998.14%
|
-
|
-
|
-
|
-
|
-
|
-
|
-221.92%
|
Earnings before Tax (EBT)
1 |
-59.36
|
-48.05
|
-23.32
|
-26.65
|
-30.45
|
-29.18
|
-20.74
|
-22.21
|
Net income
1 |
-59.21
|
-48.02
|
-23.31
|
-26.64
|
-30.44
|
-29.16
|
-20.73
|
-22.2
|
Net margin
|
-10,036.27%
|
-
|
-
|
-
|
-
|
-
|
-
|
-222%
|
EPS
2 |
-24.00
|
-16.50
|
-8.100
|
-8.400
|
-4.800
|
-4.500
|
-3.300
|
-3.600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/08/20
|
18/08/21
|
04/11/21
|
17/02/22
|
12/05/22
|
18/08/22
|
03/11/22
|
16/02/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
16.7
|
61.3
|
123
|
5.48
|
-
|
169
|
45.2
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-151
|
-111
|
-85.4
|
-
|
-
|
-45
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-43.9%
|
-32.4%
|
-24.8%
|
-27.3%
|
-
|
-9.97%
|
-93.4%
|
-
|
ROA (Net income/ Total Assets)
|
-29.7%
|
-22.2%
|
-18%
|
-19.4%
|
-
|
13.9%
|
-9.8%
|
-
|
Assets
1 |
497.3
|
487.6
|
543
|
528.5
|
-
|
-13.12
|
685.5
|
-
|
Book Value Per Share
2 |
-
|
129.0
|
66.50
|
53.00
|
-
|
0.5700
|
0.0400
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.13
|
0.07
|
-
|
-
|
-
|
0.5
|
0.51
|
-
|
Capex / Sales
|
5.95%
|
11.22%
|
-
|
-
|
-
|
0.25%
|
0.55%
|
-
|
Announcement Date
|
11/03/20
|
18/02/21
|
17/02/22
|
16/02/23
|
25/04/24
|
-
|
-
|
-
|
Last Close Price
2.33
NOK Average target price
48
NOK Spread / Average Target +1,960.09% Consensus |
1st Jan change
|
Capi.
|
---|
| -67.64% | 1.74M | | +3.91% | 109B | | +10.87% | 105B | | +1.28% | 22.25B | | -13.14% | 22.09B | | -7.05% | 18.68B | | -38.36% | 17.58B | | -10.66% | 16.85B | | +3.75% | 13.76B | | +36.70% | 12.46B |
Bio Therapeutic Drugs
|